SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 399 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,000 | -98.9% | 46 | -99.1% | 0.00% | -96.0% |
Q2 2020 | $847,000 | -6.0% | 4,983 | -36.2% | 0.08% | -21.9% |
Q1 2020 | $901,000 | -45.0% | 7,809 | -45.6% | 0.10% | -23.8% |
Q4 2019 | $1,639,000 | +703.4% | 14,345 | +148.4% | 0.13% | +180.0% |
Q1 2015 | $204,000 | – | 5,775 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |